[Research progress on bidirectional effect of microRNA on Alzheimer's disease and intervention with traditional

Li-Li Gu1, Qin Li1, Ning-Zi Wu1

  • 1Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, Hangzhou Medical College Hangzhou 310013, China.

Insights

MicroRNAs (miRNAs) show altered expression in Alzheimer's disease (AD), impacting disease pathology. This study reviews miRNA's dual role in AD and traditional Chinese medicines that modulate miRNAs for potential AD treatments.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory loss, amyloid plaques, and neurofibrillary tangles.
  • MicroRNAs (miRNAs) are small non-coding RNAs increasingly recognized for their role in regulating gene expression relevant to AD pathophysiology.
  • Abnormal miRNA expression is a hallmark of AD, suggesting their involvement in disease development and progression.

Purpose of the Study:

  • To elucidate the neuroprotective and neurotoxic effects of miRNAs in the context of Alzheimer's disease.
  • To investigate traditional Chinese medicines (TCMs) capable of modulating miRNA expression for AD treatment.
  • To establish a foundation for understanding the miRNA-AD pathogenesis relationship and guide the development of novel TCM-based anti-AD therapies.

Main Methods:

  • Literature review of studies on miRNA function in Alzheimer's disease.
  • Analysis of research on traditional Chinese medicines targeting miRNA pathways in AD.
  • Synthesis of findings to connect miRNA dysregulation, AD pathology, and TCM interventions.

Main Results:

  • MicroRNAs exhibit both beneficial and detrimental effects on neuronal function and survival in AD models.
  • Specific miRNAs are dysregulated in AD patients, correlating with disease-related gene expression.
  • Several TCMs demonstrate the ability to modulate aberrant miRNA levels implicated in AD.

Conclusions:

  • MicroRNAs are critical players in Alzheimer's disease pathogenesis, offering potential therapeutic targets.
  • Traditional Chinese medicines hold promise for regulating miRNA expression and mitigating AD progression.
  • Further research into miRNA-TCM interactions can lead to innovative strategies for Alzheimer's disease treatment.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
467
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
958
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.7K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.5K